New Drug Approvals

JUNE 11, 2025

However, in 2012 it once again failed to convince the FDA of its qualities for treating anxiety and depression. [5] 5] In December 2015, the FDA once again gave gepirone a negative review for depression due to concerns of efficacy. [12] 12] However, in March 2016, the FDA reversed its decision and gave gepirone ER a positive review. [13]

FDA 62

FDA FDA Approval Treatment Clinical Trials 62

New Drug Approvals

APRIL 19, 2025

Landiolol 133242-30-5 ONO-1101 Ono 1101 WHO 7516 FDA APPROVED 11/22/2024, Rapiblyk , To treat supraventricular tachycardia C25H39N3O8 509.6 “Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias” Clinical Pharmacology and Therapeutics. Procedure no.:

FDA 62

FDA Clinical Trials Treatment Trials 62

Metabolite Tales Blog

APRIL 4, 2023

Metabolism of 2022 FDA approved small molecule drugs part 2 Mixing it Up By Julia Shanu-Wilson In Part 1 of this topic we looked at metabolism of the small molecule drugs approved by the FDA in 2022 that were mediated by CYP3A4. 2008 Mar;153 Suppl 1(Suppl 1):S82-9. We hope it was a useful two-parter!

Small Molecule 52

Small Molecule FDA Approval FDA Drugs 52

Drug Target Review

SEPTEMBER 19, 2023

In spite of current success and possibility to be a successful cell technology model, the integration of organ-on-chips into drug development process needs more optimisation to be validated for FDA approval.

Animal Testing 98

Animal Testing Clinical Trials Pharmaceutical Companies FDA 98

The Pharma Data

JUNE 28, 2021

There are currently no FDA-approved anticoagulation therapies for pediatric patients with congenital heart disease who have undergone the Fontan procedure. Xarelto is approved in more than 130 countries, although the approved labelling, including the number of indications may differ from country to country.

FDA 52

FDA Clinical Trials Treatment Therapies 52

New Drug Approvals

APRIL 23, 2025

7] Pharmacokinetics In the kidneys , probenecid is filtered at the glomerulus , secreted in the proximal tubule and reabsorbed in the distal tubule. “Clinical pharmacokinetics of probenecid” Clinical Pharmacokinetics. Jump up to: a b Silverman W, Locovei S, Dahl G (September 2008). 6 (2): 135151. PMID 7011657.

Pharmacokinetics 62

Pharmacokinetics FDA Production Regulations 62

New Drug Approvals

APRIL 5, 2025

2488-90, 2008): A reaction mixture of dimethyl-L-tartrate (5.0g), p-toluene sulfonic acid (0.0064g) and p- anisaldehyde dimethylacetal (5.35g) in toluene (25ml) was refluxed and the azeotropical mixture of toluene-methanol was continuously removed from the reaction mixture for 3-5 hours. . Food and Drug Administration (FDA).

FDA 62

FDA FDA Approval Production Treatment 62